This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A 2006 edition of Current Pharmacology published an article titled: “Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes”. Cannabinoid Receptors , referred to as CB1 and CB2, are an essential part of the human body’s endocannabinoid system.
There is a growing body of anecdotal and scientific evidence that the “major cannabinoids” tetrahydrocannabinol (THC) and cannabidiol (CBD), certain “minor cannabinoids” (some without a name), and other cannabis compounds have antineoplastic action against cancer cells. THC binds to two types of cannabinoid receptors, CB1 and CB2.
Endorphins have long been connected to the runner’s high phenomenon, but new research has found that cannabinoid receptors—the very ones cannabinoids from cannabis bind to—play a key role. . According to Marusak, there are several decades worth of research proving that exercise is beneficial for one’s health.
As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states.
Previous research has found that THC may be effective for some cases that do not respond well to Ritalin. . Endometriosis is a poorly-understood condition causing severe chronic pain and alterations in a woman’s menstrual cycle. Cannabinoid crystals. Self medicating for endometriosis.
Individuals who use cannabis-based medications often want to cure their cancer, not just reduce the symptoms that come with the condition. Before we dive into the research, here’s the lowdown: Important takeaway points on cannabis and cancer Your situation is unique. 1 So can cannabis cure cancer? The answer: Maybe!
The 29th annual International CannabinoidResearch Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.
A team of researchers at Australia’s University of Queensland and at Botanix Pharmaceuticals Limited found, for the first time, that CBD is effective in killing Gram-negative bacteria which could mean that a new class of antibiotics can be developed for bacteria which is resistant to other forms of pharmaceutical medications. .
This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. We’ll explore the diverse range of cannabinoids and their health benefits, providing insights into how these compounds are revolutionizing healthcare.
The presence of cannabinoid receptors is well-documented and plays a crucial role in the body’s response to cannabinoids. While these receptors are crucial for regulating pain, immune function, and mood, the possibility of individuals lacking cannabinoid receptors altogether raises intriguing questions.
Fernando Fandio-Sende has had countless conversations with patients with autoimmune conditions. We’re aware that each person’s medical condition presents unique challenges with can be deeply personal. Dr. Sende offers Medical Marijuana recommendations for patients with one of Floridas qualifying conditions.
Instead, it is hypothesised that SalA indirectly influences the cannabinoid system, as well as being an allosteric modulator of the µ opioid receptor. We’re thrilled to be pursuing SalA and progressing research, as we strive for new treatments.”. BERLIN, Aug.
The team found that a cannabinoid known as CBG is the key to impeding the growth of glioblastoma cells, in turn extending life expectancy and reducing the effects of the condition. . CBG, or Cannabigerol , is a cannabinoid compound from the cannabis plant. What is CBG? What is Glioblastoma? .
THCjd, also known as Tetrahydrocannabinol jd, is a cannabinoid that has gained attention in recent years. However, research on the specific benefits and effects of THCjd is still in the works. THCjd is a recent cannabinoid discovery as of 2020. However, THCjd is touted as a non-intoxicating cannabinoid.
Cannabinoids, such as THC and CBD, interact with the endocannabinoid system in the brain, influencing mood, stress response, and emotional regulation. For conditions like anxiety and PTSD, certain strains with higher CBD content may provide calming effects without the psychoactive properties associated with THC.
The Epilepsy Foundation defines epilepsy as a chronic condition of the brain which causes seizures and affects 65 million people worldwide. One in 26 people will develop epilepsy in their lifetime. It is not fully known the genetic origins of epilepsy or if the condition is hereditary. appeared first on.
As the medical community delves into the therapeutic potential of cannabis, certain health conditions have emerged as primary candidates for its prescription. Cannabinoids, the active compounds in marijuana, interact with the endocannabinoid system in the body, modulating pain perception and inflammation.
In Florida, glaucoma is listed as a condition eligible for medical marijuana treatment. Cannabinoids and other compounds found in marijuana have been studied for their potential effects on glaucoma, a group of painful eye conditions that can lead to blindness. The use of cannabinoids for glaucoma is not without limitations.
The 29th annual International CannabinoidResearch Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.
NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.
Research Team to Study the Impact of CBD on Spinal Injury Pain. million of NWS Health funding for their Cannabinoid Therapeutics and Brain and Mind Centre to see if cannabidiol can be that effective treatment for spinal cord injury. Dr. Carins is a postdoctoral researcher who completed her Ph.D. Along with the $1.7
The National Academies of Sciences reports that PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. The psychological symptoms that develop because of the trauma affect mood, cognition, memories (both suppression and the inability to form new memories) and physical health.
In Miami, Dr. Fernando Fandio-Sende researches innovative approaches to OCD treatment that have emerged, with medical marijuana integrative wellness strategies increasingly recognized as a potential therapeutic avenue worth exploring. This gives us another way to think about treating the condition.
Australia’s Victorian government says Agriculture Victoria Research scientists have developed the world’s most complete medicinal cannabis genomic reference. The organisation has been licensed by the Australian Government to undertake medicinal cannabis research. Hemp Gazette reports. Source: [link].
I wanted to see just how good cannabis might be for this condition, and so I decided to go over the available research. Both genetic and environmental factors play a role in developing this disease. Lupus usually starts to develop between the ages of 14 and 45, but it can happen anytime. Here’s what I found.
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.
Researchers have turned to a surprising ally in this fight in recent years: cannabidiol , or CBD. Interestingly, the research demonstrated that even small doses of CBD were sufficient to produce these positive effects. The findings were nothing short of remarkable. This enzyme was inhibited by CBD by 50%.
Recent scientific studies suggest that different cannabinoids and other cannabis-derived molecules (e.g terpenes ) may help treat a number of different skin conditions. Researchers are still in the early stages of learning how exactly cannabinoids affect skin health, but some of the results are compelling.
Ulcerative Colitis is a condition that causes long-lasting inflammation and ulcers (sores) in the innermost lining of the individual’s large intestine and rectum. Crohn’s Disease is also a condition that causes inflammation, but it affects the lining of the digestive tract, which can then spread deeply into the affected tissues. .
So, let’s dig into the environmental factors of cannabis growth and development, broken down into the shoots and the roots. For new growers, understanding how light influences cannabis growth and development is essential for growing big, healthy, plants. They’ll start showing up during the flowering stage of growth and development.
As the perception of medical marijuana evolves and an increasing number of individuals explore its therapeutic potential, it’s crucial to develop a comprehensive understanding of cannabis’ impact on bodily systems. One area of interest and ongoing research is the relationship between cannabis and the immune system.
There’s no doubt that cannabis helps Rosenfeld’s condition, but it’s not a cure. According to a 2012 study by University of Bonn scientist Andras Bilkei-Gorzo: “On the cellular level, the cannabinoid system regulates the expression of brain-derived neurotrophic factor and neurogenesis.”
Until recently, there has been little to no research available that examines the effects of cannabis in patients diagnosed with Obsessive-Compulsive Disorder (OCD). Thanks to an ever increasing interest in the medical benefits of cannabis, a study was recently conducted that researched the acute effects of cannabis on the symptoms of OCD.
The use of cannabis in scientific research in the US has been at a standstill for the last five decades. The limit on where scientists could access cannabis for research was limited to just one facility at the University of Mississippi. What does federally funded cannabis research mean for medical marijuana development?
Endometriosis is a condition in which tissue similar to the tissue that comprises the lining of the uterus grows in other organs, commonly the ovaries and the fallopian tubes. However, because it has no way to exit the body, it remains trapped, causing painful cysts to develop. Cannabis for Pain Management. Treating Endometriosis.
.–(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoidresearch, has appointed Nicolas Schlienz, Ph.D., as its Research Director, a new role in the organization’s leadership. RoC is committed to research into novel healthcare options to improve quality of life. About Realm of Caring.
Professors and professionals in the cannabis field will deliver research and educational presentations from 12:30-4:20 p.m. Presenters include representatives from Southern Illinois University, Female Orgasm Research Institute, St. at the Garden Grove Event Center in Carbondale on May 4. 3:30 p.m. – 3:30 p.m. – Marialle A.
These are just a sampling of the close to 100 known cannabinoids found in marijuana. The properties and effects of major cannabinoids such as THC and CBD are generally well known within the medical marijuana community, but they are far from the only components of the cannabis plant that hold potential health and therapeutic benefits.
These essential oils are called Terpenes, and while research is still evolving, science has proven that these oils can drastically improve a patient’s quality of life. The European Journal of Pharmacology stated that this effect “ may represent a novel route for molecular regulation of endogenous cannabinoid activity.”
As of 2020, more states allow for some type of legal cannabis use than do not, and there is growing public interest in expanding the number of medical conditions that qualify for medical marijuana approval. What Does Available Cannabis Research Tell Us? What Does Available Cannabis Research Tell Us?
#image_title Families affected by Huntington’s Disease (HD) know to well that this hereditary neurodegenerative condition progressively impacts movement, cognition, and behavior, profoundly affecting both patients and their loved ones. “Every patient I see brings more than just their symptoms.”
The use of cannabinoids in the treatment of medical conditions offers major opportunities and challenges to anyone operating in the space. Prohibition Partners has identified at least 30 late-stage clinical trials using cannabinoid therapeutics, any of which will probably have a large impact on the medicinal cannabis space.
Medical marijuana has been a hot topic over the years – from the stigma it surrounds the cannabis industry to its legalization in US states and its research and use for treating various ailments. Let’s go over the three main components of ECS to better understand, they are: endocannabinoids, cannabinoid receptors, and enzymes.
Extensive research in the United States and England on cannabis in the 1930s came to a halt with the beginning of World War II and did not pick up again afterwards due to the various laws and regulations that classified the plant as a drug.Legal issuescontinued to inhibit serious study until half a century ago, when Prof.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content